Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-Cov-2) Among Healthcare Providers Prior to the Vaccine Era in an Integrated Midwestern Healthcare System

Authors

Elie A. Saade, Case Western Reserve UniversityFollow
Xiaochun Zhang, Case Western Reserve UniversityFollow
Jaime H. Noguez, Case Western Reserve UniversityFollow
Lisa M. Stempak, Case Western Reserve UniversityFollow
Daniel Tisch, Case Western Reserve UniversityFollow
Christine Schmotzer, Case Western Reserve UniversityFollow
Robert A. Salata, Case Western Reserve UniversityFollow

Author ORCID Identifier

Elie A. Saade

Xiaochun Zhang

Jaime H. Noguez

Daniel Tisch

Christine Schmotzer

Robert A. Salata

Document Type

Article

Publication Date

3-23-2022

Abstract

We performed severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antinucleocapsid IgG testing on 5,557 healthcare providers and found a seroprevalence of 3.9%. African Americans were more likely to test positive than Whites, and HCWs with household exposure and those working on COVID-19 cohorting units were more likely to test positive than their peers.

Publication Title

Antimicrobial Stewardship & Healthcare Epidemiology

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Recommended Citation

Saade EA, Zhang X, Noguez JH, Stempak LM, Tisch D, Schmotzer C, and Salata RA. (2022). Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among healthcare providers prior to the vaccine era in an integrated midwestern healthcare system. Antimicrobial Stewardship & Healthcare Epidemiology, https://doi.org/10.1017/ash.2022.29